Status:
COMPLETED
Prevention of Milk-Borne Transmission of HIV-1C in Botswana
Lead Sponsor:
Harvard School of Public Health (HSPH)
Conditions:
HIV Infection
Infant Risk for HIV Infection by MTCT
Eligibility:
FEMALE
15-45 years
Phase:
NA
Brief Summary
The purpose of this study is to find the most effective and safe treatment to prevent the passage of HIV from an infected mother to her baby.
Detailed Description
1. To assess the effectiveness of the addition of a single dose of nevirapine (NVP) to Zidovudine (ZDV, also known as AZT) as used in the Botswana mother-to-child transmission (MTCT) National Program,...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Mothers must be no more than 34 weeks pregnant, intending to carry to term, intending to stay in area for at least 7 months, and consenting to HIV-1 testing and participation; HIV-1 infected by ELISA confirmed by Western blot; etc.
Exclusion
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00197587
Start Date
August 1 2002
Last Update
May 20 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.